In the specialized field of biochemical research, the Bid BH3 peptide has emerged as a significant molecular tool. As someone deeply interested in the structural biology of the BCL-2 protein family, I have spent considerable time reviewing the literature surrounding the BH3 interacting-domain death agonist, or BID. This peptide is a fascinating subject, particularly for those exploring how specific protein domains influence mitochondrial membrane permeability and cellular signaling pathways.
The Role of Bid as a BH3-Only Protein
The To study the contribution of the hydrophobic core to the heterodimerization of Bcl-2 family proteins, we determined the affinity ofBid BH3-domain peptidewith Read more Bid BH3 peptide is derived from a pro-apoptotic member of the BCL-2 family. To understand its function, one must look at the broader context: Bid is a BH3-only protein that acts as a critical control point. Structurally, the BID (BH3 Interacting Domain Death Agonist) is known to function as a sentinel for various cellular signals.
When researchers discuss the Bid BH3 domain peptide, they are often referring to synthetic sequences—such as those cataloged as Bid BH3 Peptide - PB16919—designed to mimic the natural interaction between the BID protein and its partners. In my experience reviewing these materials, the precision of the synthetic sequence is paramount. Whether it is the 80-99 fragment or other variations, the peptide must be synthesized with high purity to maintain its Bid BH3 Peptide | PB16919 ability to interact with BAX or BCL-2.
Mechanisms of Action: Beyond Simple Binding
A key aspect that makes the Bid BH3 peptide a compelling by T Kaufmann·2007·Cited by 252—Bid, a caspase-activated proapoptotic BH3-only protein,is essential for Fas-induced hepatocyte destruction. Recent studies published in Read more study is that BID has both BH3 domain-dependent and -independent modes of action. While many associate the Bid peptide primarily with its role as a death-inducing ligand, its capacity to modulate the mitochondrial pathway is nuanced.
In laboratory settings, BID-like BH3 peptides and their counterparts have been utilized to investigate how these molecules induce caspases and influence mitochondrial outer membrane integrity. It is well-documented that Bid BH3-domain peptide affinity for proteins like BCL-xL is a foundational metric for researchers measuring binding kinetics. Furthermore, the observation that BH3 peptides also displayed synergy in certain experimental models highlights the complexity of the BCL-2 family network.
Quality Considerations in Research Peptides
When sourcing these materials for research—whether it is the BID, Control Peptide or a specific Bid BH3 domain Bid BH3 Peptide | PB16919 peptide—the quality of the synthesis is critical. I have noted that high-grade peptides are often lyophilized to ensure stability. The BH3-interacting domain death agonist (BID, p22 BID) is a complex molecule, and researchers should look for suppliers who provide detailed mass spectrometry and HPLC data.
The Bid protein plays in apoptotic cell death through a mechanism that involves moving from the cytosol to the mitochondrial membrane. Because the Bid BH3 peptide is a truncated fragment of this larger protein, it serves as an excellent surrogate for studying these specific protein-protein interactions without the regulatory constraints of the full-length protein.
Summary of Research Insights
* Entity Identification: The BH3 Interacting Domain Death Agonist (BID) is categorized as a protein-coding gene.
* StandardPeptideSynthesis: NovoPro offers qualitypeptidesat the most competitive prices in the industry, starting at .20 per amino acid. NovoPro provides Read more Functional Focus: The Bid BH3 peptide acts Bidis a pro-apoptotic member of theBH3-only (BOPS) subset of the BCL-2 family of proteins that constitute a critical control point in apoptosis.Read more as a molecular probe to study the Bcl-2 family of proteins.
* Experimental Utility: These peptides are essential for understanding how the Bid BH3 domain facilitates heterodimerization.
For those of us observing these developments, the study of the Bid BH3 peptide remains 2BID: HUMAN PRO-APOPTOTIC PROTEIN BID one of the most effective ways to map the intricate signaling cascades that govern mitochondrial health. By utilizing these precise synthetic tools, we gain a clearer picture of how the Bid BH3 motif drives conformational changes in target proteins, providing invaluable data for biochemical modeling and structural analysis.